CYH Q3'26 Earnings: revenue estimate is 2.80B USD

Community Health Systems (CYH) trimmed its 2026 adjusted EBITDA guidance to $1.338B from $1.415B, citing softer commercial demand and slower payer payments. Q2 same-store admissions rose 3%, but half came from uninsured visits. Shares trade at $2.95, down 5.5% YTD. Management focuses on cost control and ambulatory growth.

Community Health Systems (CYH) shares rose 7.2% since its last earnings report. The company reported a wider-than-expected Q2 2026 loss of 19 cents per share and lowered its 2026 revenue and EBITDA guidance. Net operating revenues declined 9.8% YoY to $2.8B, and total assets decreased to $12.2B. Analysts have revised estimates downward, and the stock has a Zacks Rank #3 (Hold).

More and more uninsured patients are showing up in hospital emergency rooms and clinics, having lost their coverage under the Affordable Care Act. Executives running some of the biggest hospital systems, including large for-profit chains spanning many states, expressed concern over the unexpectedly sharp rise in uninsured patients and the costs associated with treating them.

Community Health Systems Inc. (NYSE: CYH) shares fell about 13.82% on July 23, 2026 after Barclays cut its rating to Underweight from Equal Weight and reaffirmed a $3 price target, citing weaker regulatory and reimbursement conditions for acute care hospitals. The article cites recent financials including $2.97B revenue and a $58M net loss for the quarter ended 2026/03/31.

COMMUNITY HEALTH SYSTEMS INC (CYH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cyh-ex99_1.htm EX-99.1 EX-99.1 Exhibit Number 99.1 Investor Contact: Kevin Hammons Director and Chief Executive Officer (615) 465-7000 COMMUNITY HEALTH SYSTEMS, INC. ANNOUNCES SECOND QUARTER ENDED JUNE 30, 2026 RESULTS FRANKLIN, Tenn. (July 22, 2026) – Community Health

Boeing reported a record $745.4B backlog, with commercial orders covering 6,300 airplanes. However, production delays pushed stock down 15.5% to $168.18, a 52-week low. Q3 revenue was $24.2B with a net loss of $116M. CEO Ortberg expects production rate increases in 2027, but cash flow targets shifted to 2029. Defense revenue rose 15% to $7.9B.